Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int Orthop ; 47(11): 2809-2826, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37612523

RESUMEN

PURPOSE: The two stage revision procedure is the gold standard surgical technique in chronic shoulder periprosthetic joint infection (PJI). Series of one stage revision have been published with similar outcomes but with preoperative selection of patients. The aim of this work was to report the outcomes (infection eradication, functional, and radiographic) after systematic one stage revision, without preoperative selection of patients, in chronic shoulder PJI. METHODS: This was a retrospective monocentric study including 40 patients (14 women and 26 men) with a diagnosis of periprosthetic joint infection after a shoulder arthroplasty. A one stage shoulder prosthesis revision was performed in all patients, for a PJI evolving for more than three weeks, without preoperative patient selection. The primary endpoint was the absence of signs of persistent infection at a minimum follow-up of two years. Secondary endpoints were clinical and radiological outcomes. RESULTS: At the last follow-up, 36/40 patients had no recurrence of infection after the one stage revision, i.e., 90% of our series. In 45% (18/40) of the cases, the microbial organism was not known at the time of the one stage revision. Cutibacterium acnes was the most frequent pathogen, found in 67.5% (27/40) of the patients. The infection was polymicrobial in 40% (16/40) of the cases. At last follow-up, mean absolute Constant score was 48.4% (16-93) and weighted score was 65.5% (22-100), and satisfaction was evaluated by the patients as excellent or good in 75% (30/40). About 20% (8/40) of the patients had a postoperative complication. CONCLUSION: A one stage revision procedure, combined with appropriate antibiotic therapy, made it possible to eradicate the PJI in 90% of the shoulders in our series with satisfactory functional outcomes.


Asunto(s)
Artritis Infecciosa , Artroplastía de Reemplazo de Hombro , Infecciones Relacionadas con Prótesis , Articulación del Hombro , Masculino , Humanos , Femenino , Artroplastía de Reemplazo de Hombro/efectos adversos , Estudios Retrospectivos , Infección Persistente , Infecciones Relacionadas con Prótesis/epidemiología , Infecciones Relacionadas con Prótesis/etiología , Infecciones Relacionadas con Prótesis/cirugía , Antibacterianos/uso terapéutico , Artritis Infecciosa/cirugía , Reoperación/efectos adversos , Resultado del Tratamiento
2.
J Arthroplasty ; 36(12): 3973-3978, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34511281

RESUMEN

BACKGROUND: The use of antibiotic-loaded acrylic cement for treating periprosthetic joint infections remains controversial. We hypothesized that the raw rate of surgical site infection (SSI) is lower after using cement loaded with high-dose gentamicin and clindamycin than after using cement loaded with standard-dose gentamicin for implant fixation during 1-stage hip and knee revision arthroplasty for infection. METHODS: One hundred seventy-one continuous patients operated by 2 experienced surgeons during a 2-year period were included in the study. All patients were followed for 24 months. The primary endpoint was the raw rate of SSI after 2 years of follow-up time. RESULTS: The raw rate of SSI after 2 years of follow-up time was significantly lower in the study group (13%) than in the control group (26%) (P = .03) with an odds ratio of 0.42 (P = .03). These SSIs were new infections rather than a recurrence/persistence of the initial infection. CONCLUSION: The cement used in the study group significantly reduced the risk of SSI relative to the cement used in the control group. Routine use of this high-dose dual antibiotic-loaded cement can be considered during 1-stage knee or hip revision arthroplasty for infection.


Asunto(s)
Artroplastia de Reemplazo de Cadera , Artroplastia de Reemplazo de Rodilla , Infecciones Relacionadas con Prótesis , Antibacterianos/uso terapéutico , Artroplastia de Reemplazo de Cadera/efectos adversos , Artroplastia de Reemplazo de Rodilla/efectos adversos , Cementos para Huesos , Clindamicina/uso terapéutico , Gentamicinas , Humanos , Infecciones Relacionadas con Prótesis/tratamiento farmacológico , Infecciones Relacionadas con Prótesis/epidemiología , Infecciones Relacionadas con Prótesis/prevención & control , Reoperación , Estudios Retrospectivos
3.
Open Forum Infect Dis ; 6(7)2019 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-31363768

RESUMEN

During the 2017-2018 flu epidemic, the point-of-care Alere-i (n = 72) and reverse transcription polymerase chain reaction (n = 106) tests were compared. Patients in the point-of-care group were administered oseltamivir significantly more rapidly (9 hours vs 23 hours), they spent less time in the emergency department, and they had lower rates of antibiotic administration and hospitalization.

4.
J Rheumatol ; 45(3): 425-429, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29335349

RESUMEN

OBJECTIVE: To report efficacy and tolerance of interleukin 1 blockade in adult patients with mevalonate kinase deficiency (MKD). METHODS: We retrospectively collected data on 13 patients with MKD who had received anakinra (n = 10) and canakinumab (n = 7). RESULTS: Anakinra resulted in complete or partial remission in 3/10 and 5/10 patients, respectively, and no efficacy in 2/10, but a switch to canakinumab led to partial remission. Canakinumab resulted in complete or partial remission in 3/7 and 4/7 patients, respectively. CONCLUSION: These data support frequent partial responses, showing a better response with canakinumab. The genotype and therapeutic outcomes correlation should help in the personalization of treatment.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antirreumáticos/uso terapéutico , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Deficiencia de Mevalonato Quinasa/tratamiento farmacológico , Adolescente , Adulto , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales Humanizados , Antirreumáticos/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas , Niño , Preescolar , Tolerancia a Medicamentos , Femenino , Francia , Humanos , Infecciones/inducido químicamente , Reacción en el Punto de Inyección/etiología , Proteína Antagonista del Receptor de Interleucina 1/efectos adversos , Proteína Antagonista del Receptor de Interleucina 1/farmacología , Interleucina-1beta/antagonistas & inhibidores , Masculino , Medicina de Precisión , Inducción de Remisión , Estudios Retrospectivos , Resultado del Tratamiento , Aumento de Peso/efectos de los fármacos
5.
Opt Express ; 13(14): 5387-92, 2005 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-19498533

RESUMEN

We report on transient laser action during the photopolymerization process in organic thin films of acrylate monomers doped with a laser dye. The emission spectrum was monitored over a period of time in the direction orthogonal to the incident laser beam which is kept at a constant intensity during the experiments. The emission spectra display the signature of laser action after a certain amount of polymerization. We have also recorded the intensity of fluorescence as well as of the amplified stimulated emission (ASE) using a photodiode. Our results confirmed that all the emission is guided by an increase of the refractive index resulting from the photopolymerization process. The spatial fluctuations in the density of the material are thought to act as micro-cavities leading to a random laser effect.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...